HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies
Crossref DOI link: https://doi.org/10.1136/openhrt-2018-000823
Published Online: 2018-07-11
Published Print: 2018-07
Update policy: https://doi.org/10.1136/crossmarkpolicy
Laurence, Jeffrey
Elhadad, Sonia
Ahamed, Jasimuddin https://orcid.org/0000-0001-6455-0296
Funding for this research was provided by:
National Institute of General Medical Sciences
Division of Cancer Prevention, National Cancer Institute
National Heart, Lung, and Blood Institute
